Money Never Sleeps: Cash
Build-up on Corporate Balance Sheets
While critics have raised alarms
about the rising cash holdings on corporate balance sheets, there are broader,
long-term reasons for the move to cash that go far beyond a knee-jerk reaction
by business to current economic uncertainty, according to a new report from the
C.D. Howe Institute.
In “Not Dead Yet: The Changing
Role of Cash on Corporate Balance Sheets,” Finn Poschmann finds corporate cash
holdings have increased in waves over the past quarter-century in response to
changing economic conditions and business process improvements.
“The critics’ outcry over corporate
cash hoards, which has gone so far as to accuse business of malfeasance, is
mistaken,” commented Poschmann. “A closer look suggests more to the story.”
Poschmann finds that while
corporate cash as a share of assets has risen in the past decade, the share of
other, non-income-earning current asset components, such as inventories and
accounts receivable, has significantly fallen. “Businesses appear to have been
responding to long-term trends in economic conditions, including enhanced
business processes that have shrunk inventories, by better managing their
balance sheets,” said Poschmann. “Businesses have been shoring up financial
assets to match liabilities, in part for precautionary reasons; there is no
economic problem or market failure to be addressed and, accordingly, no policy
action indicated in response,” noted the author.
Poschmann provides in-depth
evidence for his argument in data going back to the 1950s, which show that
businesses, overall, are keeping less inventory on hand for reasons that range
from the global shipping container revolution to better management information
systems and just-in-time delivery methods. These changing business conditions,
along with a precautionary approach to economic headwinds, tell the real story,
said Poschmann. “Assets held in cash-like forms, which earn interest, and
provide cushions against unexpected events, can fund future investments and are
a lot less dormant than holdings in inventories and accounts receivable, which
typically have zero returns.”
1 comment:
Aurobindo Pharma board okays raising USD 350 million via QIP.Epic Research provide market recommendation.
Post a Comment